‼️Lo studio scientifico condotto dal dirigente dell’Istituto Superiore della Sanità e finanziato dal Ministero della Salute conferma l’inefficacia e la enorme pericolosità dei cosiddetti “vaccini”-Covid-19 a mRNA, a tutt’oggi consigliati per le donne incinte, donne allattanti, personale sanitario (incluso gli studenti del reparto sanitario) e i “fragili” - CONFERMA DELLA SCELLERATEZZA delle politica anche dell’attuale Ministro della (Non-)Salute ‼️ Con uno studio scientifico pubblicato il 14.11.2024 su MDPI 👇👇👇 https://www.mdpi.com/2076-393X/12/11/1281 il dirigente dell’ISS Maurizio Federico - non senza la “dovuta” (altrimenti non viene pubblicato lo studio) dichiarazione della presunta dei vaccini tradizionali (in realtà mai dimostrata con veri studi clinici, come a breve verrà accertato e dimostrato in via istituzionale negli USA) - dimostra e spiega: 🔻1. la scarsissima efficacia dei cosiddetti “vaccini” a mRNA alla prevenzione della malattia Covid-19, dato che il virus entra dalle vie respiratorie, dove i vaccini iniettati nel muscolo del braccio di fatto rimangono senza efficacia. Questo fatto fondamentale era stato evidenziato sin dall’inizio a livello internazionale da esperti come Prof.Dr. Sucharit Bhakdi - professore emerito di microbiologia Università di Mainz (Germania) e Prof. Michael Palmer - professore emerito di microbiologia (Università di Waterloo, Canada) - vedi nel loro libro sui vaccini a mRNA il capitolo 2.7. - spiegano nel dettaglio anche l’enorme pericolosità di questi sier sperimentali) 👇👇👇 https://drive.google.com/file/d/1hkxyo3v2NpiyetyHU6QCZe_KZF1PJ-n_/view?usp=drivesdk 🔻2. L’altissima pericolosità dei cosiddetti “vaccini” a mRNA, che però ancora oggi nella campagna vaccinale 2024/2025 vengono consigliati alle donne incinte, donne allattanti, agli over 60, al personale sanitario (inclusi studenti) e a tutti cosiddetti “fragili” il cui sistema immunitario è già fuori equilibrio per altri motivi. 👇👇👇 https://t.co/g79Be7Jgpk Lo studio finanziato dal Ministero della Salute dimostra che i cosiddetti “vaccini” a mRNA causano malattie autoimmuni, infiammazioni croniche e inducono lo sviluppo e la riattivazione di tumori maligni! La scelta dell’attuale Ministro della Salute di continuare a consigliare questi nudi e crudi veleni per l’essere umano, nonostante che gli stessi produttori avessero dichiarato - e a tutt’oggi lo fanno - che li mancano le informazioni sugli effetti, che queste sostanze sperimentali hanno, sulle donne incinte ed allattanti e sulle persone con problemi preesistenti nel loro sistema immunitario (dunque in prima linea per tutte le persone cosiddette fragili!) è di singolare scellerataggine! 🔻Cosa fa adesso Orazio Schillaci con questo studio schiacciante finanziato dal Ministero da lui diretto e fatto da un dirigente dell’ISS? 🔻Che fine fa la raccomandazione da parte del Ministero della (Non-)Salute di queste sostanze mortali? 🔻E che fine fanno Orazio Schillaci e Francesco Vaia? che - se avrebbero un minimo di decenza - dovrebbero dimettersi subito dalla loro rispettiva carica di Ministro alla Salute e Direttore Generale della Prevenzione Sanitaria. Fonte: https://x.com/RHolzeisen/status/1858042453292367886?t=4vk1NMGO0eyL2E2CR0YXhA&s=19

LA LUCIDA ANALISI FATTA COME SEMPRE da Roy de Vita. Ascoltate chi c'è sempre stato dietro la FDA e anche per EMA ed AIFA c'è il solito marciume. MASSIMA CONDIVISIONE!!! THE CLEAR ANALYSIS MADE AS ALWAYS by Roy de Vita. Listen to those who have always been behind the FDA and also for EMA and AIFA there is the usual rot. MAXIMUM SHARING!!! #RobertKennedyJr: La Sanità americana dovrebbe essere affidata a lui. Panico nelle file avverse - Roy de Vita #roydevita #fda #fdagate #modernagate

Il governo della Provincia Autonoma di Bolzano contrario alla revisione critica delle misure Covid – continua a negare persino fatti istituzionalmente confermati e cerca di non farmi dire la verità nel Consiglio Provinciale, minacciando la mia espulsione dall‘Aula! 👇👇👇 https://www.renate-holzeisen.eu/it/comunicato-stampa-17/?amp=1 Il Governo provinciale dell’Alto Adige – in primis l’Assessore responsabile della salute degli altoatesini Hubert Messner – non ha alcuna intenzione di attuare una revisione critica delle misure pandemiche, revisione che è – invece – essenziale per il futuro. E questo nonostante una promessa nel programma di governo. L’assessore Messner continua a sostenere che i cosiddetti “vaccini” Covid-19 sarebbero stati autorizzati per la prevenzione dell’infezione virale e quindi per l’inibizione della trasmissione del virus! Da ultimo, rispondendo ad una delle mie interrogazioni, che evidentemente danno fastidio alla Giunta provinciale, in Aula del Consiglio Provinciale lo scorso 5.11.2024. Riguardava, tra le altre, la mia interrogazione sui motivi per i quali il Governo provinciale dell’Alto Adige non ha concesso (come confermato dall’Assessore competente Ulli Mair) agli inquilini “non-vaccinati” contro il Covid-19 di un appartamento dell’IPES (Istituto Provinciale dell’Edilizia Sociale) – che si trovano in difficoltà finanziari< a causa della sospensione dal lavoro senza retribuzione per tanti mesi – la riduzione dell’affitto sociale a cui per legge provinciale hanno diritto tutti coloro che si trovano in difficoltà economiche senza colpa, nonchè sui motivi  per i quali a questi inquilini poi è stato addirittura disdetto dall’IPES il contratto di affitto. https://drive.google.com/file/d/1Rd2fOysZeAroqu3QPNyQaXJ5vcEhUHNy/view?usp=drivesdk Nella sua risposta alla mia interrogazione, l’Assessore Messner ha ripetuto una volta di più la gravissima disinformazione – diffusa dai politici sin dalla fine del dicembre 2020 – e secondo la quale i cosiddetti “vaccini” Covid-19 sarebbero stati autorizzati per la prevenzione dell’infezione virale e quindi per l’inibizione della trasmissione virale – e che quindi non vi sarebbe stato alcun uso off-label (cioè al di fuori dall’indicazione terapeutica del “vaccino”) sui  cittadini obbligati a vaccinarsi ai fini della prevenzione del contagio con il virus SARS-CoV-2. E ciò nonostante il fatto che il contrario emergesse in modo inequivocabile sin dall’inizio dai documenti di autorizzazione all’immissione in commercio e ora viene confermato anche da tribunali italiani! Poiché anche l’EMA e l’AIFA hanno confermato che i cosiddetti “vaccini” Covid-19 non sono mai stati autorizzati per la prevenzione del contagio virale, ci possono essere solo due ragioni per la diffusione di falsità da parte dell’Assessore Messner: o l’Assessore Messner non è in grado di leggere i documenti ufficiali di autorizzazione dei farmaci ed è affetto da una dissonanza cognitiva persino rispetto a conferme esplicite da parte dell’EMA e dell’AIFA, oppure sta cercando di coprire il proprio irresponsabile operato degli ultimi anni, continuando a diffondere una eclatante disinformazione. Entrambe le situazioni sono inaccettabili per un medico, ex primario e ora Assessore alla Salute. Va ricordato che Hubert Messner si dichiarò favorevole pure alla “vaccinazione” Covid-19 dei bambini al fine di una presunta “immunità di gregge”! È evidente che Hubert Messner è incorso in una enorme responsabilità personale per aver consigliato il trattamento di bambini e adolescenti con sostanze sperimentali pericolose (miocardite, morte indicati tra i possibili effetti collaterali anche nel foglietto illustrativo!) e che non sono mai state autorizzate allo scopo di inibire la trasmissione del virus, come invece da lui ancora oggi sostenuto! E ovviamente tenta di sottrarsi a questa grave responsabilità negando pure l’innegabile! 👇👇👇 Qui ulteriori dettagli scandalosi anche sul fatto che cercano di non farmi dichiarare in Consiglio Provinciale la Verità!

https://www.decidim.barcelona/profiles/abroad_gateway80/activity https://www.rcuniverse.com/forum/members/abroadgateway80.html https://gifyu.com/abroadgateway80 https://slides.com/abroadgateway80 https://topbazz.com/Abroadgateway80 https://about.me/gateway80 https://www.lanikaibrewing.com/profile/abroadgateway80/profile https://www.nutrociencia.com.br/profile/abroadgateway80/profile https://www.ikraupvc.co.id/profile/abroadgateway80/profile https://www.recentstatus.com/Abroadgateway80 https://jobs.njota.org/profiles/5541481-abroad-gateway80 https://pastewall.com/43642/wall/1 http://molbiol.ru/forums/index.php?showuser=1398999 https://www.in-pocasi.cz/uzivatele/abroadgateway80-127916/

CAR T Cell Therapy Market Emerging Trend, Opportunities, Key Players, Huge Growth, Revenue Analysis, 2023-2035 The latest report entitled ‘CAR T Cell Therapy Market’ by Roots Analysis provides an accurate estimation of the market size, regional landscape description, and revenue forecast over the projected timeframe. The current global CAR T-cell therapy market size is likely to be worth USD 4.6 billion, and is projected to reach worth USD 15.2 billion by 2035, growing at a CAGR of 11.4% during the period, till 2035. The report turns the spotlight on the major challenges faced by the key players in the global market and the growth strategies currently adopted by them. The report is a granular assessment of this particular business sphere and entirely covers the dynamic competitive landscape of the market. The document offers key insights into the market positions of these players alongside their gross earnings. Furthermore, it elaborates on each of the market segments, with detailed scrutiny of the development scope and competitive scenario of the regional fragments of the market. The latest study is inclusive of an in-depth analysis of the economic status of the CAR T Cell Therapy Market and examines the most important regions constituting the global market. It further details on the most lucrative and growth-oriented regions, top market rivals, diversified product types, and a large number of end-use industries. Key factors affecting the growth of the CAR T Cell Therapy Market: Geographical Overview: • The latest report broadly categorizes the CAR T Cell Therapy Market into several geographical terrains, including North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa and Rest of the World. • The study is inclusive of essential information relevant to each region in this broad industry segment, along with the key drivers of the regional market growth. • The report further estimates the revenue accumulated by these regions over the forecast period. Competitive Hierarchy: • The latest research report studies the major market players, their regional presence, industry share, and production facilities. • The report offers significant data pertaining to these market competitors’ company profiles, product types, and application outlook. • Moreover, the pricing models and gross margins of these industry majors have also been mentioned in the report. Key players Autolus, Bluebird Bio, Bristol Myers Squibb, Carsgen Therapeutics, Cellectis, Gilead Sciences, Innovative Cellular Therapeutics, Noile-Immune Biotech, Novartis, Shanghai GeneChem, Sinobioway Cell Therapy, Takara Bio and Wellington Zhaotai Therapies. Additional parameters of the CAR T Cell Therapy Market report: • The latest research study endows the reader with a comprehensive analysis of the product types of the CAR T Cell Therapy Market, categorizing the relevant information into the Distribution by Target Inidcation, Target Antigens and Key Geographical Regions. The study focuses on the wide-ranging application landscape of the market, segmenting it into the market share, estimated growth rate, and the forecast product demand for each application type. Additional Insights: • The market concentration rate and processing rate of raw materials have also been conscripted in the report. • The report contains an assessment of the current price trends, as well as the factors influencing the global market size. • It throws light on the significant marketing strategies implemented by the eminent players in the industry. • Vital data and information concerning the producers, distributors, and downstream buyers involved in the global market, as well as the cost structure analysis and market mechanism, form the important elements of this report. Research objectives: • The CAR T Cell Therapy Market report studies the worldwide market consumption rate in terms of value and volume. • It identifies the various sub-segments of the market structure. • It proffers information regarding the leading global manufacturers in this industry, describing their market value & share, sales volume, competitive analysis, SWOT analysis, and development strategies adopted during the forecast timeline. • The report describes the key industry players, with respect to their individual growth trends, future prospects, and contribution to the global market, and explains the factors related to their market growth potential, drivers, opportunities, threats, and industry-specific challenges. • Furthermore, the report underpins the strategic developments occurring in the CAR T Cell Therapy Market, such as expansions, mergers & acquisitions, agreements, as well as new product launches. To view more details on this report, click on the link https://www.rootsanalysis.com/reports/car-t-cell-therapy-market/269.html About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way. The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide. Contact: Roots Analysis +1 (415) 800 3415 Sales@rootsanalysis.com

The Advantages of China CA Zn Stabilizer in PVC Applications The China CA Zn stabilizer is revolutionizing the PVC industry with its exceptional properties and environmentally friendly profile. This calcium-zinc-based stabilizer offers a non-toxic alternative to traditional lead stabilizers, making it an ideal choice for manufacturers prioritizing sustainability. One of the standout features of the CA Zn stabilizer is its remarkable thermal stability. It enables PVC products to endure high processing temperatures without degrading, resulting in enhanced mechanical properties such as improved tensile strength and flexibility. This robustness makes it suitable for a wide range of applications, including pipes, profiles, and films, where durability is essential. In addition to its performance benefits, the CA Zn stabilizer ensures excellent color stability and transparency, enhancing the aesthetic appeal of final products. Its compatibility with various processing methods allows manufacturers to streamline production while maintaining high-quality standards. As industries increasingly focus on eco-friendly practices, the China CA Zn stabilizer is emerging as a go-to solution for producing safe, durable, and attractive PVC products. By integrating this innovative stabilizer into their formulations, manufacturers can meet both performance and environmental standards, positioning themselves as leaders in sustainable manufacturing. https://www.zjhongtian.com/product/

32000 Medici pagati dalle case farmaceutiche.pdf CERCATE NEL FILE. TROVERETE DELLE SORPRESE.

The research analysis on the global Sterilization Equipment Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Sterilization Equipment Market circumstances in the forecast period between 2024 and 2031. The global Sterilization Equipment Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Read More @ https://www.skyquestt.com/report/sterilization-equipment-market

https://linkingdirectory.com/author/abroadgateway81-17775/ https://www.7cups.com/@Abroadgateway81 https://fitinline.com/profile/abroadgm3/ https://seedly.sg/profile/abroad-gateway-d2b96323-694e-47e8-8256-5b66cbedae27/ https://jobs.windomnews.com/profiles/4955276-abroad-gateway https://collectednotes.com/abroadgateway81/unknown https://www.mothering.com/members/abroadgateway81.477334/#about https://uplink.weforum.org/uplink/s/profile/005TE000004XhtW https://www.dnxjobs.de/users/Abroadgateway81 https://submitarticlesblog.com/author/abroadgateway81/ https://buildd.co/u/abroad_gateway_975 https://pitchwall.co/user/abroadgateway81 https://www.ubertheme.com/profile/abroadgateway81/ http://idea.informer.com/users/Abroadgateway81/?what=personal https://fstoppers.com/profile/abroadgateway81 https://www.inflearn.com/users/@abroadgateway https://vietfones.vn/forum/members/abroadgateway81.250788/ https://www.fundable.com/abroad-gateway-1 https://developer.cisco.com/user/profile/e799deef-0be3-5922-9801-7691c490b6dc https://www.curioos.com/abroadgateway81 https://www.myminifactory.com/users/abroadgateway2 https://files.fm/abroadgateway81 https://maxternmedia.com/author/abroadgateway81 https://opencollective.com/abroad-gateway https://biomolecula.ru/authors/30428 https://www.zerohedge.com/user/tZNamnV0LXVDWw4e9ambNzIe54D3 https://bootstrapbay.com/user/Abroadgateway81 https://robertsspaceindustries.com/citizens/Abroadgateway81 https://www.scenario.press/Abroadgateway81

Brain Health Supplements Market Global outlook 2024 to 2031 The research analysis on the global Brain Health Supplements Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Brain Health Supplements Market circumstances in the forecast period between 2024 and 2031. Read More @ https://www.skyquestt.com/report/brain-health-supplements-market